Liraglutide injections vs insulin for uncontrolled type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial compares two treatment approaches—liraglutide injections versus a specific insulin (glargine) injection—plus meal-time insulin dosing (“bolus”) in adults with overweight/obesity and type 2 diabetes that isn’t well controlled. The goal is to see which option works better and is safer for improving blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your body mass index (BMI) is over 24 and under 45.
- You have type 2 diabetes that meets common diagnostic standards.
- Your blood sugar marker (HbA1c) is high enough—either newly diagnosed (HbA1c ≥ 9%) or previously treated/uncontrolled (HbA1c ≥ 7.5% despite at least two oral diabetes pills, or insulin).
- You can sign the consent form and understand study instructions.
- You do not have certain exclusions like serious recent heart problems or stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two weight-loss medicines: liraglutide (a daily injection) and orlistat (a pill), given alone or together, over 24 weeks. It aims to see which approach is safer and works better for people who are overweight or have obesity.
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
This study tests if combining exercise with a drug called liraglutide improves blood vessel health and insulin sensitivity in people with type 2 diabetes. It looks at whether these treatments work better together or alone.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
This study compares two injectable medications, RAY1225 and semaglutide, added to your usual diabetes pills, to see how well they control blood sugar and affect weight. It aims to help improve glucose control in people with type 2 diabetes.
Hear when a new Type 2 Diabetes Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.